Lotus BioScience Ventures

Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.

Number of Investments

Number of Lead Investments

6

0

Lotus BioScience Ventures has made 6 investments. Their most recent investment was on Sep 23, 2008, when Humanigen raised $20M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 23, 2008 Humanigen	Series D	$20M	Biopharma	—
Oct 19, 2005 Nereus Pharmaceuticals	Series D	$42.60M	Biotechnology	—
Aug 11, 2005 Anadys Pharmaceuticals	Private Equity（PE）	$71.30M	Biotechnology	—
Mar 16, 2005 Humanigen	Series B	$20M	Biopharma	—
Jun 24, 2002 Infinity Pharmaceuticals	Series B	$70M	Biopharma	—

Lotus BioScience Ventures has had 5 exits. Lotus BioScience Ventures most notable exits include Humanigen , Nereus Pharmaceuticals

Date	Company Name	Exit Type	Industry
Aug 7, 2017	Humanigen	IPO	Biopharma	Detail
Jan 1, 2012	Nereus Pharmaceuticals	M&A	Biotechnology	Detail
Oct 17, 2011	Anadys Pharmaceuticals	M&A	Biotechnology	Detail
Aug 4, 2009	Infinity Pharmaceuticals	IPO	Biopharma	Detail
Feb 19, 2004	Dynavax Technologies	IPO	Biopharma	Detail